BioSpace News Archive

Policy

David Dodd and Philip Theodore Respond to Claim By AEterna Zentaris

David Dodd, the former CEO of AEterna Zentaris and a director of the Company, and Philip Theodore, the Company’s former General Counsel, have responded to the claim filed against them by the Company in Ontario, delivering their defence and affidavits in support of their position.

August 7, 2017
·
1 min read
Business

Appointment And Reappointment To The Institute For Research In Immunology And Cancer Of The Université De Montréal Board Of Directors

August 7, 2017
·
2 min read
Business

MYnd Analytics Adds Experienced Sales & Marketing Executive

August 7, 2017
·
3 min read
FDA

CMP Pharma Announces FDA Approval Of CaroSpir (Spironolactone Oral Suspension, 25 Mg/5 mL)

August 7, 2017
·
3 min read
Business

HitGen And LEO Pharma Enter Research Collaboration

August 7, 2017
·
2 min read
Pharm Country

John Theurer Cancer Center And Medstar Georgetown University Hospital Announce 100th Blood Stem Cell Transplant

August 7, 2017
·
8 min read
Drug Development

Biohaven Completes Randomization In Phase II/III Trial In Spinocerebellar Ataxia: Expected Topline Data Advanced To Fourth Quarter Of 2017

August 7, 2017
·
6 min read
Business

Orexigen Announces Commercialization And Distributorship Arrangement With Cheplapharm Arzneimittel GmbH For Mysimba In Germany, France And Austria

August 7, 2017
·
7 min read
Business

DePuy Synthes Announces Exclusive Co-Marketing Agreement With Medical Enterprises Distribution, LLC To Further Transform Hip Replacement With New Automated Technology

August 7, 2017
·
5 min read
Business

Ritter Pharma Reports Second Quarter 2017 Financial Results And Provides Business Update

August 7, 2017
·
9 min read